New pain block could reduce opioid use after mastectomy
NCT ID NCT07367568
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two types of nerve blocks to control pain after modified radical mastectomy. 110 women will receive either a costotransverse foramen block or an erector spinae plane block, both using the numbing drug bupivacaine. The goal is to see which block reduces the need for morphine and provides better pain relief in the first two days after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If one block works better, it could mean less pain and less need for strong painkillers after mastectomy.
- What could go wrong
- This is a small, early-stage trial comparing two established techniques. It may not show a clear winner, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cairo University
RECRUITINGCairo, 12613, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?